New oxygen tube aims to make lung scopes safer

NCT ID NCT07389083

Recruiting now Symptom relief Sponsor: First Affiliated Hospital of Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new way to give oxygen during a sedated lung scope (bronchoscopy). Normally, patients can have dangerously low oxygen levels because the scope and sedation block the airway. The new method uses a thin, flexible tube placed through the nose to deliver oxygen directly above the voice box. The trial will enroll 50 adults to see if this reduces low-oxygen events compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: wire-reinforced tracheal tube (device)
What this could lead to: If successful, this could offer a safer, more effective way to deliver oxygen during bronchoscopy, reducing the risk of dangerously low oxygen levels.
What could go wrong: This is a small, early-stage feasibility study with only 50 participants. The device may not work as hoped, or could cause discomfort or injury (e.g., nosebleeds).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Deception Hypoxia respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOXIA PULMONARY INFECTION PULMONARY NODULE

Contacts and locations

Locations

The First Affiliated Hospital of Zhejiang University
RECRUITING

Hangzhou, Zhejiang, 310000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.